Tradestie Institutional Equity Comparison Engine

MYO vs TCMD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TCMD Overall Edge

TCMD Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tactile Systems Technology, Inc. (TCMD) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MYO trades at N/M Forward P/E with -21.8% operating margin (+22.2% YoY revenue) versus TCMD at 17.4x Forward P/E and 9.4% operating margin (+7.1% YoY). In options structure, MYO sits in UNCLASSIFIED (81st %ile IV; Dealer Gamma Walls on Pro) against TCMD sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TCMD
MYO N/M vs TCMD 17.4x Fwd P/E
Growth & Margin Winner TCMD
Op Margin -21.8% vs 9.4% ยท YoY +22.2% vs +7.1%
Momentum & Technical Winner TCMD
1Y +12.3% vs +5.7% ยท 52W Pos 16% vs 29%
Options & Structure Winner TCMD
UNCLASSIFIED (81st %ile IV) vs CONSOLIDATION (15th %ile IV)
MYO NYSE American
Myomo Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.81
-3.45% 1D
Market Cap $33.7M
1M Return -33.52%
1Y Return +12.3%
Forward P/E N/M
Unified AI Score
40.1 / 100 SELL
Tech 25.0 Fund 43.0 Flow 58.0 Mom 59.0
TCMD NASDAQ
Tactile Systems Technology, Inc.
Surgical & Medical Instruments & Apparatus
$25.60
-1.5% 1D
Market Cap $582.2M
1M Return +8.75%
1Y Return +5.65%
Forward P/E 17.4x
Unified AI Score
40.1 / 100 SELL
Tech 37.0 Fund 44.0 Flow 65.0 Mom 31.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MYO +12.3% TCMD +5.65% Spread: +6.65 pp (MYO Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MYO Revenue TCMD Revenue MYO Op. Margin TCMD Op. Margin Margin Edge
FY2018 $0M $140M -430.8% 2.1% TCMD
FY2019 $0M $190M -281.3% 5.5% TCMD
FY2020 $10M $190M -138.5% -1.9% TCMD
FY2021 $10M $210M -74.1% -0.8% TCMD
FY2022 $20M $250M -68.6% -5.2% TCMD
FY2023 $20M $270M -42.8% 6.6% TCMD
FY2024 $30M $290M -19.1% 7.6% TCMD
FY2025 $40M $330M -35.2% 8.9% TCMD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MYO (1) vs TCMD (8)
Institutional Metric MYO TCMD Criterion Row Winner
Market Capitalization Scale $33.7M $582.2M Larger Scale TCMD
Trailing P/E Ratio Valuation N/M 25.2x Lower Multiple TCMD
Forward P/E Ratio Valuation N/M 17.4x Lower Multiple TCMD
Revenue Growth (YoY) Growth +22.2% +7.1% Higher Growth MYO
Operating Margin (TTM) Profitability -21.8% 9.4% Higher Margin TCMD
Net Profit Margin Profitability -33.1% 6.7% Higher Margin TCMD
Return on Equity (ROE) Capital Efficiency -173.5% 11.0% Higher ROE TCMD
52-Week Range Position Momentum 16% ($1โ€“$2) 29% ($21โ€“$38) Stronger Trend TCMD
Beta / 30D Volatility Risk Regime 2.22ฮฒ ยท 107% Vol 0.95ฮฒ ยท 52% Vol Lower Realized Risk TCMD
Unified Institutional Score Composite Signal 40.1 / 100 (SELL) 40.1 / 100 (SELL) Higher Composite Tie

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MYO vs TCMD Buy Guide
MYO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 81st %ile
IV Regime Extreme (>80th %ile)
Live MYO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TCMD CONSOLIDATION
98d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live TCMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MYO nor TCMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.